drugset / Trial / NCT00108316

Determinants in Antidepressant Outcomes

NCT00108316

Non-randomizedSingle-groupOpen-label

Summary

This study is designed to understand if a biological measurement, of how platelets respond to serotonin (a chemical in the blood sometimes referred to as SERT), can provide information that will determine an "ideal dose," one specifically tailored for each individual's chemistry. The biological measurement will be obtained by testing a blood sample. There will be approximately 120 control subjects expected for enrollment.

Timeline

Start
2004-01
Primary completion
2005-09
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluoxetine Small molecule

Indications